Clinical Trial Update: Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency [NA]

View source ↗

Summary

A long-term trial evaluating optimal antiproteinuric doses of benazepril and losartan in chronic kidney disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Benazepril (Benazepril)
• Losartan (losartan)

Snippet

Sponsor: Southern Medical University, China | Conditions: Renal Insufficiency,Chronic, Disease Progression | NA | Status: TERMINATED